Tadalafil PAH OrPha 20 mg, Filmtabletten - 56 Swissmedic Key 67968001 Registration Holder OrPha Swiss GmbH Name Tadalafil PAH OrPha 20 mg, Filmtabletten Date of registration 23.07.2020 Original/Generic Generic Introduction of Sequence 23.07.2020 ATC-Classification Tadalafil (G04BE08) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 20000. Show package size 56 Index Therapeuticus (Swissmedic) 02.07.10. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 358.36 Limitation Yes Limitation text
Deductible 10 % Consumer price 406.15 Feedback FB Daily cost GTIN 7680679680012 Medication Code Synthetika Pharmacode Disponibility ●
Composition tadalafilum 20 mg, lactosum 312.5 mg, carmellosum natricum conexum, natrii laurilsulfas, hydroxypropylcellulosum, polysorbatum 80, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 2.8 mg, E 171, triacetinum, talcum, E 172 (flavum), pro compresso obducto corresp. natrium 1.91 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Tadalafilum 20 mg
BAG: Active Agent Dose Tadalafilum 20 mg
Inactive agents Dose additional_information (Flavum) Carmellosum Natricum Conexum E 171 color. E 172 color. Hydroxypropylcellulosum Hypromellosum Überzug Lactosum 312.5 mg Lactose Monohydrate 2.8 mg Magnesii Stearas Natrii Laurilsulfas Polysorbatum 80 Pro Compresso Obducto Talcum Triacetinum
Source Data was imported : 08.07.2026
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
